Elagolix - Latest Advances

Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review.

Journal: Cureus

Published: September 12, 2025

CalOPT: A Specialty Pharmacy-Dietitian Quality Improvement Initiative for Calcium Optimization in Patients with Osteoporosis Risk.

Journal: Pharmacy (Basel, Switzerland)

Published: April 22, 2025

Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research.

Journal: Journal of clinical medicine research

Published: March 15, 2025

Oral GnRH antagonists for ovulation suppression during ovarian stimulation protocols: systemic review and meta-analysis.

Journal: Journal of assisted reproduction and genetics

Published: February 10, 2025

Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial.

Journal: Reproductive biomedicine online

Published: February 08, 2025

Elagolix for ovulation suppression in in vitro fertilization: Is it time to switch from the painful costly injectables?

Journal: F&S reports

Published: January 09, 2025

Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: January 02, 2025

The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

Journal: Expert opinion on drug metabolism & toxicology

Published: December 12, 2024

Recent Trends in Medical Management of Endometriosis.

Journal: Journal of obstetrics and gynaecology of India

Published: December 05, 2024

Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.

Journal: Obstetrics and gynecology

Published: December 05, 2024

The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization.

Journal: Expert review of clinical pharmacology

Published: November 08, 2024

A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding.

Journal: Gland surgery

Published: September 03, 2024

Filters

Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review.

Efficacy of Elagolix and Relugolix for the Treatment of Pelvic Pain in Patients With Endometriosis: A Systematic Review.

CalOPT: A Specialty Pharmacy-Dietitian Quality Improvement Initiative for Calcium Optimization in Patients with Osteoporosis Risk.

CalOPT: A Specialty Pharmacy-Dietitian Quality Improvement Initiative for Calcium Optimization in Patients with Osteoporosis Risk.

Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research.

Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research.

Oral GnRH antagonists for ovulation suppression during ovarian stimulation protocols: systemic review and meta-analysis.

Oral GnRH antagonists for ovulation suppression during ovarian stimulation protocols: systemic review and meta-analysis.

Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial.

Prolonged oral GnRH-antagonist administration before euploid embryo transfer in patients with endometriosis: a prospective randomized pilot non-inferiority trial.

Elagolix for ovulation suppression in in vitro fertilization: Is it time to switch from the painful costly injectables?

Elagolix for ovulation suppression in in vitro fertilization: Is it time to switch from the painful costly injectables?

Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.

Significance of gut breast cancer resistance protein versus organic anion transporting polypeptide 2B1 inhibition on rosuvastatin clinical drug-drug interactions.

The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

Recent Trends in Medical Management of Endometriosis.

Recent Trends in Medical Management of Endometriosis.

Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.

Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.

The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization.

The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization.

A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding.

A systematic review and meta-analysis comparing the use of elagolix therapy alone or in combination with add-back therapy to treat women with uterine fibroid associated heavy menstrual bleeding.